HERAMED LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0175 AUD | -12.50% |
|
0.00% | -27.08% |
| Mar. 13 | HeraMED Partners With FemBridge for Maternity Health Service; Shares Jump 15% | MT |
| Mar. 11 | Heramed Limited Announces Board Changes | CI |
Presenter SpeechTim Chapman (Attendees)Good morning, everyone. Welcome to today's HeraMED webi...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetusâ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -27.08% | 4.03M | |
| +4.55% | 3.48B | |
| -12.80% | 156M | |
| -15.69% | 81.85M | |
| +30.43% | 59.71M |
- Stock Market
- Equities
- HMD Stock
- News HeraMED Limited
- Transcript : HeraMED Limited - Special Call
